handok pharmaceuticals co
(002390:Korea Stock Exchange (Koscom))

Last 16,800 KRW

Change Today +100.00 / 0.60%

Volume 13.3K

002390 On Other Exchanges

Symbol

Exchange

002390:KS

As of 2:10 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

handok pharmaceuticals co (002390) Snapshot

Open 16,600		Previous Close 16,700
Day High 16,850		Day Low 16,600
52 Week High 12/10/12 - 33,650		52 Week Low 07/25/12 - 10,200
Market Cap 194.9B		Average Volume 10 Days 24.7K
EPS TTM 497.00		Shares Outstanding 11.6M
EX-Date 12/27/12		P/E TM 33.8x
Dividend 150.00		Dividend Yield 0.89%

Current Stock Chart for HANDOK PHARMACEUTICALS CO (002390)

002390:KS Historical Stock Quote
002390:KS Advanced Stock Chart

Related News

No related news articles were found.

handok pharmaceuticals co (002390) Related Businessweek News

No Related Businessweek News Found

handok pharmaceuticals co (002390) Details

Handok Pharmaceuticals Co., Ltd. develops, manufactures, and sells pharmaceutical products. It provides various prescription, over-the-counter, and ETC drugs; and medical devices, as well as offers contract manufacturing services. It is also involved in the research and development of small molecule products for the treatment of metabolic and cardiovascular diseases, such as Type II diabetes, hyperlipidemia, and hypertension; central nervous system diseases comprising Parkinson’s disease, Alzheimer’s disease, and schizophrenia; pain and digestive disorders, as well as provides oncology drugs. In addition, the company engages in the research and development of various biologics products, which are in early development stage for the treatment of hemophilia, rheumatoid arthritis, and cancer. Handok Pharmaceuticals Co., Ltd. was founded in 1954 and is based in Seoul, South Korea. Handok Pharmaceuticals Co., Ltd. operates as a subsidiary of Sanofi.

Detailed 002390:KS Company Description...

www.handok.co.kr

Founded in 1954

handok pharmaceuticals co (002390) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

handok pharmaceuticals co (002390) Key Developments

Handok Pharmaceuticals Co., Ltd. Proposes Amendments to Bylaws

Mar 11 13

Handok Pharmaceuticals Co., Ltd. proposed amendments to the bylaws of the company in its shareholders' annual meeting to be held on March 29, 2013.

Handok Pharmaceuticals Co., Ltd., Annual General Meeting, Mar 29, 2013

Mar 11 13

Handok Pharmaceuticals Co., Ltd., Annual General Meeting, Mar 29, 2013., at 10:00 Korea Standard Time. Location: 735, Korea Handok drugs Building, Convention Hall. Agenda: To consider and approve the financial statements for the period from January 1, 2012 to December 31, 2012 and the payment of dividends; to consider election of Directors; to consider appointment of audit committee member; to approve of directors' remuneration limit; and to consider amendment to bylaws.

Handok Pharmaceuticals Co., Ltd. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013

Feb 7 13

Handok Pharmaceuticals Co., Ltd. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.